1. Treatment of Hypoalbuminemia
(1) Diet Therapy: Nephrotic syndrome patients are usually in negative nitrogen balance. If they can consume a high-protein diet, they may convert to positive nitrogen balance. However, consuming high protein by nephrotic syndrome patients can lead to increased urine protein, aggravating glomerular damage, without an increase in plasma albumin levels. Therefore, it is recommended to consume 1g of protein per kilogram per day, plus the amount of protein lost in urine each day. For every 1g of protein consumed, 138kJ (33kcal) of non-protein calories must be consumed simultaneously. The supplied protein should be high-quality protein, such as milk, eggs, fish, and meat.
(2)Intravenous infusion of albumin: since the albumin infused intravenously is lost through urine from the kidney within 1-2 days and is expensive. In addition, large-scale intravenous use of albumin has side effects such as immunosuppression, hepatitis C, triggering heart failure, delaying remission, and increasing recurrence rate, so strict indications should be strictly controlled when using intravenous albumin: ①Severe general edema, in patients who cannot achieve diuretic effects with intravenous injection of Furosemide, after intravenous infusion of albumin, followed by intravenous infusion of Furosemide (120mg of Furosemide added to 100-250ml of glucose solution, slowly infused for 1 hour), it is often possible for those who were previously ineffective to Furosemide to still achieve good diuretic effects. ②Clinical manifestations of plasma volume deficiency after diuretic with Furosemide. ③Acute renal failure caused by interstitial edema.
2. Treatment of edema
(1)Sodium-restricted diet:
Edema itself suggests an excess of sodium in the body, so it is of great importance to limit salt intake in patients with nephrotic syndrome. The daily salt intake of a normal person is 10g (containing 3.9g of sodium), but due to the tasteless diet after sodium restriction, the appetite is poor, which affects the intake of protein and calories. Therefore, the sodium-restricted diet should be moderate so that the patient can tolerate it without affecting their appetite, and the salt content of a low-sodium diet is 3-5g/d. Chronic patients, due to long-term sodium restriction, may lead to intracellular sodium deficiency, which should be paid attention to.
(2)Application of diuretics:
Diuretics can be divided according to different action sites:
①Loop diuretics: the main mechanism of action is to inhibit the reabsorption of chloride and sodium in the thick ascending limb of the loop of Henle, such as Furosemide (Lasix) and Bumetanide (Bumetanide) are the most powerful diuretics. The dose is 20-120mg/d for Furosemide, and 1-5mg/d for Bumetanide.
②Thiazide diuretics: mainly act on the thick ascending limb of the loop of Henle (cortical region) and the anterior segment of the distal tubule, by inhibiting the reabsorption of sodium and chloride, and increasing potassium excretion to achieve diuretic effects. The usual dose of hydrochlorothiazide is 75-100mg/d.
③Sodium-reabsorbing potassium diuretics: mainly act on the distal tubules and collecting ducts, and are aldosterone antagonists. The usual dose of Spironolactone is 60-120mg/d, the effect of using such drugs alone is poor, so they are often used in combination with potassium-wasting diuretics.
④Osmotic diuretics: can be freely filtered through the glomerulus without being reabsorbed by the renal tubules, thereby increasing the osmotic concentration of the renal tubules and preventing the reabsorption of water and sodium by the proximal and distal tubules, thereby achieving diuretic effects. The usual dose of low-molecular-weight dextran is 500ml/2-3d, mannitol 250ml/d, and caution should be exercised in patients with renal function damage.
The preferred diuretic for nephrotic syndrome patients is Furosemide, but the dosage varies greatly among individuals; intravenous administration is more effective, the method is: add 100mg of Furosemide to 100ml of glucose solution or 100ml of mannitol, and slowly drip for 1 hour; Furosemide is a potassium-wasting diuretic, so it is often used in combination with Spironolactone. After long-term application (7-10 days) of Furosemide, the diuretic effect decreases, and sometimes the dosage needs to be increased, and it is best to change to intermittent administration, that is, to stop the drug for 3 days before using it again. It is recommended that diuretics with different action sites be used in combination and alternately for patients with severe edema.
3. Treatment of hypercoagulable state
Patients with nephrotic syndrome are in a hypercoagulable state due to changes in coagulation factors, especially when plasma albumin is below 20-25g/L, there is a possibility of venous thrombosis. Currently, the commonly used anticoagulant drugs in clinical practice include:
(1) Heparin: Mainly activates the anticoagulant activity of antithrombin III (ATⅢ). The usual dose is 50-75mg/d intravenous infusion, so that the activity unit of ATⅢ is above 90%. Some literature reports that heparin can reduce proteinuria in nephrotic syndrome and improve renal function, but the mechanism of action is not clear. It is noteworthy that heparin (MW 65600) can cause platelet aggregation. Currently, there is a low molecular weight heparin for subcutaneous injection, once a day.
(2) Urokinase (UK): Directly activates plasminogen, leading to fibrinolysis. The usual dose is 20,000-80,000 U/d, start with a low dose, and can
It is administered intravenously with heparin. Monitor the euglobulin lysis time to keep it between 90-120 minutes. The main side effects of UK are allergy and bleeding.
(3) Warfarin: Inhibits the synthesis of vitamin K-dependent factors II, VII, IX, and X in liver cells, the usual dose is 2.5mg/d, taken orally, and monitor the prothrombin time to keep it at 50%-70% of normal people.
(4) Dipyridamole: A platelet antagonist, the usual dose is 100-200mg/d. The anticoagulation time for venous anticoagulation in general hypercoagulable state is 2-8 weeks, and then changed to warfarin or dipyridamole oral administration.
4. Treatment of hyperlipidemia
Patients with nephrotic syndrome, especially those with frequent recurrence, have a long duration of hyperlipidemia. Even after the nephrotic syndrome is relieved, hyperlipidemia still persists. In recent years, it has been recognized that hyperlipidemia affects the progression of kidney disease. Some drugs used to treat nephrotic syndrome, such as adrenal cortical hormones and diuretics, can worsen hyperlipidemia, so it is currently recommended to use lipid-lowering drugs for hyperlipidemia in nephrotic syndrome.
The lipid-lowering drugs that can be used include: ①Fibric acid derivatives (fibric acids): Fenofibrate, taken three times a day, 100mg each time, Gemfibrozil, taken twice a day, 600mg each time; this drug has a stronger effect on lowering blood triglycerides than on lowering cholesterol. This medicine occasionally causes gastrointestinal discomfort and an increase in serum transaminases. ②Hmg-CoA reductase inhibitors: Lovastatin (Mei Jiangzhi), 20mg bid, Simvastatin (Shu Jiangzhi), 5mg bid; these drugs mainly reduce intracellular Ch, lower plasma LDL-Ch concentration, and reduce the production of VLDL and LDL by liver cells. ③Angiotensin-converting enzyme inhibitors (ACEI): The main effects include lowering the concentration of Ch and TG in plasma; increasing the level of HDL in plasma, and its main lipoprotein ApoA-Ⅰ and ApoA-Ⅱ also increase, which can accelerate the clearance of Ch in peripheral tissues; reduce the infiltration of LDL into the arterial intima, and protect the arterial wall.
5. Treatment of Acute Renal Failure
The treatment methods for nephrotic syndrome complicated with acute renal failure vary due to different etiologies. For those caused by hemodynamic factors, the main treatment principles include: rational use of diuretics, adrenal cortical hormones, correcting hypovolemia, and dialysis therapy. Hemodialysis not only controls azotemia and maintains electrolyte acid-base balance but also can quickly remove water retention in the body. Acute renal failure caused by interstitial edema can recover renal function quickly after the above treatment.
When using diuretics, attention should be paid to:
①Timely use of diuretics:
In patients with nephrotic syndrome and severe hypoalbuminemia, the use of high-dose diuretics without supplementing plasma protein will exacerbate hypoalbuminemia and hypovolemia, and further worsen renal failure. Therefore, diuretics should be administered after supplementing plasma albumin (10-50g human albumin administered intravenously per day). However, if plasma albumin is supplemented excessively without timely diuretic therapy, it may lead to pulmonary edema.
②Appropriate use of diuretics:
Due to the relative hypovolemia and tendency of hypotension in patients with nephrotic syndrome, it is advisable to use diuretics with a daily urine output of 2000-2500ml or a daily weight loss of about 1kg.
③In patients with increased plasma renin levels, the use of diuretics after the blood volume decreases can further increase the plasma renin level. Diuretic therapy is not only ineffective but also exacerbates the condition. Such patients can only benefit from diuretic therapy after correcting hypoalbuminemia and hypovolemia.
Nephrotic syndrome complicated with acute renal failure is generally reversible. Most patients recover renal function gradually with increased urine output under treatment. A few patients may experience acute renal failure multiple times during the course of the disease, which can also be recovered. The prognosis is related to the etiology of acute renal failure. Generally, rapid progressive glomerulonephritis and renal vein thrombosis have poor prognosis, while those associated solely with nephrotic syndrome have a better prognosis.